title: Angiotensin II does not contribute to rapid reflex control of arterial pressure.
abstract: Pharmacological blockade of the renin-angiotensin converting enzyme reportedly alters the heart rate (HR) power spectrum in conscious dogs, suggesting that these hormones contribute to the short-term regulation of arterial blood pressure. We tested this possibility using four independent procedures. First, HR power spectrum was determined in seven awake dogs before and after administration of enalaprilat (300 ng/kg), a converting-enzyme inhibitor. There were no significant changes in the average amplitude for the spectral peak between 0.003 and 0.1 Hz (i.e., the "low-frequency peak"). Second, the HR power spectrum was measured in 11 awake rabbits before and after treatment with deoxycorticosterone acetate (1 mg.kg-1.day-1) and salt (0.9% saline ad libitum) for 7 days to depress plasma renin levels. There were no significant changes in the amplitude of the HR power spectrum, although mean HR decreased from 206 +/- 3 to 184 +/- 4 beats/min after treatment. In the third experiment, another group of rabbits (n = 8) was tested after 2 wk on a low-salt diet to elevate plasma angiotensin levels and then after 2 wk on a normal salt diet. Once again there were no significant effects on the HR power spectrum. Finally, tranquilized dogs (n = 9) were subjected to sinusoidally varying lower body negative pressure at selected frequencies of 0.008-0.12 Hz. Tests were conducted in the control state and after administration of an angiotensin receptor antagonist (saralasin, 1 microgram.kg-1.min-1). Lower body negative pressure-induced fluctuations in arterial blood pressure were similar in both states. We find no evidence for the role of the renin-angiotensin system in the moment-to-moment regulation of arterial pressure and HR.
authors.affiliation: Center for Biomedical Engineering, University of Kentucky, Lexington 40506-00701.
authors.forename: D R
authors.initials: DR
authors.lastname: Brown
authors.forename: J D
authors.initials: JD
authors.lastname: Yingling
authors.forename: D C
authors.initials: DC
authors.lastname: Randall
authors.forename: H M
authors.initials: HM
authors.lastname: Aral
authors.forename: J M
authors.initials: JM
authors.lastname: Evans
authors.forename: J B
authors.initials: JB
authors.lastname: Charles
authors.forename: C F
authors.initials: CF
authors.lastname: Knapp
authors.forename: R
authors.initials: R
authors.lastname: Raisch
authors.forename: C E
authors.initials: CE
authors.lastname: Ott
mesh_terms: D000804:Angiotensin II / Q000494:pharmacology*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects / Q000502:physiology*; D003900:Desoxycorticosterone / Q000494:pharmacology; D004039:Diet, Sodium-Restricted; D004285:Dogs; D005260:Female; D006339:Heart Rate; D008150:Lower Body Negative Pressure; D008297:Male; D011817:Rabbits; D012018:Reflex / Q000502:physiology*; D012083:Renin / Q000097:blood; D012965:Sodium Chloride / Q000494:pharmacology; D000092502:Renin Inhibitors
chemical_list: D000804:Angiotensin II; D000806:Angiotensin-Converting Enzyme Inhibitors; D003900:Desoxycorticosterone; D012083:Renin; D012965:Sodium Chloride; D000092502:Renin Inhibitors